Light-Activated therapy shows promise for tumor control without surgery

NCT ID NCT02159742

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study follows people who have received photodynamic therapy (PDT) for various cancers, including head and neck, lung, and skin tumors. PDT uses a light-sensitive drug and a special light to destroy cancer cells while sparing healthy tissue. Researchers will review medical records to track survival, tumor recurrence, and quality of life over time. The goal is to better understand how well PDT works and how it affects organ function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
photodynamic therapy (PDT)
What this could lead to
If successful, this research could help doctors understand how well PDT controls tumors and preserves organ function, potentially improving treatment guidelines.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by incomplete records or patient follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHUS NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Abramson Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.